TMO
Thermo Fisher Scientific Inc. Information Technology Measuring & Controlling Devices, NEC S&P 500Russell 3000
$697.00Close
$310.3BMarket cap
$437.90 – $709.1852-week range
Mid-januaryNext report · estimated
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 83 · stronger than 83% of stocks over 12 months
- Near its high 2% below its 52-week high
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
2%
1wk
up 3.4%
price change
1mo
up 3.3%
price change
12-month return
up 26%
market up 11% ·
its own up 14%
F-score
—
— Not assessed
Altman Z
4.80
Low risk
P/E
46.2×
price / earnings
PEG
6.20
P/E / EPS growth
P/B
5.8×
price / book
Earnings yield
up 2.3%
EBIT / enterprise value
Cheaper than
35%
of the market · expensive
Revenue growth
up 4%
year on year
EPS growth
up 9%
latest quarter · -1 pts
Sales growth
up 9%
latest quarter · -1 pts
ROE
up 13%
return on equity
Free cash margin
up 14%
$6.3B FCF
D/E
0.73
long-term debt / equity
Net debt / EBITDA
3.8×
Interest cover
—EBIT / interest
Trade setup
ATR%
2.8%
$19.68 a day · 2×ATR $657.63
RS
83 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
1.0×
vs 50-day average
Up/down volume
1.43
50 sessions
Implied move
—
no scheduled report
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Oct 21, 2026
Results reaction
Oct 21, 2026-1% vs market2 sessions after results
Options
$3.0M32.2% IV · activity
Financials
- Net 15%
- Free cash 14%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $32.2B | $39.2B | $44.9B | $42.9B | $42.9B | $44.6B |
| Operating income | $7.8B | $10.0B | $8.4B | $6.9B | $7.3B | $7.7B |
| Net income | $6.4B | $7.7B | $7.0B | $6.0B | $6.3B | $6.7B |
| Net margin | 20% | 20% | 15% | 14% | 15% | 15% |
| Earnings per share | $15.98 | $19.47 | $17.66 | $15.35 | $16.55 | $17.78 |
| Free cash flow | $6.8B | $6.8B | $6.9B | $6.9B | $7.3B | $6.3B |
| Free cash margin | 21% | 17% | 15% | 16% | 17% | 14% |
| Cash | $10.3B | $4.5B | $8.5B | $8.1B | $4.0B | $9.9B |
| Long-term debt | $19.1B | $34.7B | $34.3B | $34.7B | $31.1B | $39.2B |
| Shareholders' equity | $34.5B | $40.8B | $44.0B | $46.7B | $49.6B | $53.4B |
| Shares outstanding | 437.09m | 439.15m | 440.67m | 442.19m | 443.84m | 445.16m |
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $647 – $746 ±7.1% by Nov 27, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- Bigger 32.2% priced · 27.9% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- Choppier
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: no change
Positioning
- Premium traded
- $3.0M calls $2.1M · puts $977,312 · latest session
- 0.47× -0.22 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls -3.40k · puts -4.81k past week
For options traders: ATM IV 32.2% (+0.4% 1w) · 1m ÷ 3m IV 1.03 · 25Δ skew 1.5 pts · Net GEX $23.4M
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 30, 2026 | Quarterly ↗ | Sep 26, 2026 | 34d |
| Jul 31, 2026 | Quarterly ↗ | Jun 27, 2026 | 34d |
| May 1, 2026 | Quarterly ↗ | Mar 28, 2026 | 34d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Oct 31, 2025 | Quarterly ↗ | Sep 27, 2025 | 34d |
| Aug 1, 2025 | Quarterly ↗ | Jun 28, 2025 | 34d |
| May 2, 2025 | Quarterly ↗ | Mar 29, 2025 | 34d |
| Feb 20, 2025 | Annual ↗ | Dec 31, 2024 | 51d |
| Nov 1, 2024 | Quarterly ↗ | Sep 28, 2024 | 34d |
| Aug 2, 2024 | Quarterly ↗ | Jun 29, 2024 | 34d |
| May 3, 2024 | Quarterly ↗ | Mar 30, 2024 | 34d |
| Feb 22, 2024 | Annual ↗ | Dec 31, 2023 | 53d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 30, 2026 | Director or officer change ↗ |
| Oct 21, 2026 | Results ↗ |
| Jul 23, 2026 | Results ↗ |
| May 26, 2026 | Shareholder vote ↗ |
| Apr 23, 2026 | Results ↗ |
| Mar 24, 2026 | Other events ↗ |
| Feb 12, 2026 | Material agreement · Other events ↗ |
| Jan 29, 2026 | Results ↗ |
| Jan 12, 2026 | Director or officer change ↗ |
| Dec 1, 2025 | Material agreement · Other events ↗ |
| Oct 29, 2025 | Other events ↗ |
| Oct 22, 2025 | Results ↗ |